Literature DB >> 15926798

Screening of protein kinases by ATP-STD NMR spectroscopy.

Mark A McCoy1, Mary M Senior, Daniel F Wyss.   

Abstract

ATP-STD NMR takes advantage of Mg2+ binding to ATP to adjust the ATP affinity for protein kinases permitting a wide range of Ki's to be determined for ATP competitive ligands. Substituting Mn2+ for Mg2+ creates a paramagnetic probe (MnATP) from which the proximity of non-ATP competitive ligands can be inferred. Internal standards and references are used to reduce false positives due to protein or compound degradation. Use of the natural ATP ligand confers active site-specificity that is not available a priori from other ligand binding experiments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15926798     DOI: 10.1021/ja0425942

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  4 in total

1.  Mitogen-activated protein kinases interacting kinases are autoinhibited by a reprogrammed activation segment.

Authors:  Ralf Jauch; Min-Kyu Cho; Stefan Jäkel; Catharina Netter; Kay Schreiter; Babette Aicher; Markus Zweckstetter; Herbert Jäckle; Markus C Wahl
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

2.  Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors.

Authors:  Xiaohua Huang; Gerald W Shipps; Cliff C Cheng; Peter Spacciapoli; Xingmin Zhang; Mark A McCoy; Daniel F Wyss; Xianshu Yang; Abdelghani Achab; Kyle Soucy; Donna K Montavon; Denise M Murphy; Charles E Whitehurst
Journal:  ACS Med Chem Lett       Date:  2011-06-24       Impact factor: 4.345

Review 3.  Biomolecular NMR: a chaperone to drug discovery.

Authors:  Marco Betz; Krishna Saxena; Harald Schwalbe
Journal:  Curr Opin Chem Biol       Date:  2006-05-05       Impact factor: 8.822

Review 4.  Small molecule substrate phosphorylation site inhibitors of protein kinases: approaches and challenges.

Authors:  Meghan E Breen; Matthew B Soellner
Journal:  ACS Chem Biol       Date:  2014-12-23       Impact factor: 5.100

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.